Amneal Pharmaceuticals, LLC recalls Ropivacaine Hydrochloride Injection
- Published
- 14 May 2025
- Units affected
- 62 (12x100mL) bags
- Agency
- FDA
- Country
- United States
The hazard
Presence of Particulate Matter
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)
- Brand / company
- Amneal Pharmaceuticals, LLC
- Codes / lots
- Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
- Distribution
- Nationwide in the US
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 14 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.